Search research articles
Contact Us
Filters
Showing results (951-960 of 1,203) with videos related to
Page
of 121
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Ivan de Kouchkovsky, Arpit Rao, Benedito A Carneiro, et al.
Endocrinology
|
November 23, 2000
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion
A M Wren, C J Small, H L Ward, et al.
Prostate Cancer and Prostatic Diseases
|
November 3, 2018
Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series
James L Mohler, Susan Halabi, Stephen T Ryan, et al.
Endocrinology
|
June 18, 2003
Central orexin A has site-specific effects on luteinizing hormone release in female rats
C J Small, M-L Goubillon, J F Murray, et al.
Journal of the National Cancer Institute
|
September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer
Lawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Journal of Obsessive-Compulsive and Related Disorders
|
August 22, 2022
Symptom Trajectories of Early Responders and Remitters among Youth with OCD
Megan Rech, Saira Weinzimmer, Daniel Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2004
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer
William K Oh, Philip W Kantoff, Vivian Weinberg, et al.
Clinical Genitourinary Cancer
|
January 6, 2015
Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF
Rahul R Aggarwal, Tomasz M Beer, Vivian K Weinberg, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
July 28, 2022
Cumulative burden of symptomatology in patients with gynecologic malignancies undergoing chemotherapy
Laura B Oswald, Sarah L Eisel, Danielle B Tometich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2009
Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a study of the department of defense prostate cancer clinical trials consortium
Jonathan E Rosenberg, Charles J Ryan, Vivian K Weinberg, et al.
Page
of 121
Search research articles
Search
Showing results (951-960 of 1,203) with videos related to
Sort By:
Page
of 121
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Ivan de Kouchkovsky, Arpit Rao, Benedito A Carneiro, et al.
Endocrinology
|
November 23, 2000
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion
A M Wren, C J Small, H L Ward, et al.
Prostate Cancer and Prostatic Diseases
|
November 3, 2018
Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series
James L Mohler, Susan Halabi, Stephen T Ryan, et al.
Endocrinology
|
June 18, 2003
Central orexin A has site-specific effects on luteinizing hormone release in female rats
C J Small, M-L Goubillon, J F Murray, et al.
Journal of the National Cancer Institute
|
September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer
Lawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Journal of Obsessive-Compulsive and Related Disorders
|
August 22, 2022
Symptom Trajectories of Early Responders and Remitters among Youth with OCD
Megan Rech, Saira Weinzimmer, Daniel Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2004
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer
William K Oh, Philip W Kantoff, Vivian Weinberg, et al.
Clinical Genitourinary Cancer
|
January 6, 2015
Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF
Rahul R Aggarwal, Tomasz M Beer, Vivian K Weinberg, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
July 28, 2022
Cumulative burden of symptomatology in patients with gynecologic malignancies undergoing chemotherapy
Laura B Oswald, Sarah L Eisel, Danielle B Tometich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2009
Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a study of the department of defense prostate cancer clinical trials consortium
Jonathan E Rosenberg, Charles J Ryan, Vivian K Weinberg, et al.
Page
of 121